BILIARY TRACT CANCER

  • cancer drugs duty waiver to benefit only astrazeneca

    Cancer drugs duty waiver to benefit only AstraZeneca

    ​The Budget exempted three cancer drugs - Trastuzumab Deruxtecan, Osimertinib and Durvalumab - from a customs levy of 10%. Trastuzumab Deruxtecan is a breast cancer drug, Osimertinib lung cancer and Durvalumab is used as lung and biliary tract cancer therapy.

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Download ETHealthworld App for Realtime updates

Seamless reading experience. Save your favourite.

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement